ATE308614T1 - Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung - Google Patents

Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung

Info

Publication number
ATE308614T1
ATE308614T1 AT97952089T AT97952089T ATE308614T1 AT E308614 T1 ATE308614 T1 AT E308614T1 AT 97952089 T AT97952089 T AT 97952089T AT 97952089 T AT97952089 T AT 97952089T AT E308614 T1 ATE308614 T1 AT E308614T1
Authority
AT
Austria
Prior art keywords
plants
derived proteins
production
recombinant collagen
collagen produced
Prior art date
Application number
AT97952089T
Other languages
English (en)
Inventor
Veronique Gruber
Jean-Yves Exposito
Florence Ruggiero
Jeanne Comte
Robert Garrone
Bertrand Merot
Philippe Bournat
Original Assignee
Meristem Therapeutics S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9499306&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE308614(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meristem Therapeutics S A filed Critical Meristem Therapeutics S A
Application granted granted Critical
Publication of ATE308614T1 publication Critical patent/ATE308614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT97952089T 1996-12-17 1997-12-17 Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung ATE308614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9616224A FR2757874B1 (fr) 1996-12-17 1996-12-17 Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
PCT/FR1997/002331 WO1998027202A1 (fr) 1996-12-17 1997-12-17 Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations

Publications (1)

Publication Number Publication Date
ATE308614T1 true ATE308614T1 (de) 2005-11-15

Family

ID=9499306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952089T ATE308614T1 (de) 1996-12-17 1997-12-17 Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung

Country Status (9)

Country Link
US (2) US6617431B1 (de)
EP (1) EP0951537B1 (de)
JP (1) JP2001507573A (de)
AT (1) ATE308614T1 (de)
AU (1) AU5563798A (de)
CA (1) CA2274807A1 (de)
DE (1) DE69734528T2 (de)
FR (1) FR2757874B1 (de)
WO (1) WO1998027202A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834909A1 (de) * 1998-08-03 2000-02-17 Mpb Cologne Gmbh Molecular Pla Faserproteine und ihre Herstellung
WO2000066732A2 (en) * 1999-04-30 2000-11-09 Biostratum, Inc. Laminin 8 and methods for its use
AU2005246967B2 (en) * 1999-11-12 2008-09-04 Fibrogen, Inc. Recombinant gelatins
DE60040012D1 (de) * 1999-11-12 2008-10-02 Fibrogen Inc Rekombinantes gelatin in impstoffen
RU2002112750A (ru) * 1999-11-12 2004-01-27 Файброджен, Инк. (Us) Коллагены и желатины животного происхождения
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
FR2807436B1 (fr) * 2000-04-10 2002-05-24 Meristem Therapeutics Methode d'obtention de fibres d'un polypeptide collagenique recombinant non-hydroxyle, et fibres de polypeptide collagenique recombinant non-hydroxyle ainsi obtenues
FR2854328B1 (fr) * 2003-04-29 2006-08-04 Rocher Yves Biolog Vegetale Composition cosmetique ou dermatologique ou pharmaceutique contenant un facteur de croissance du type vegetal de nature peptidique
US7268116B2 (en) * 2003-10-02 2007-09-11 Genhunter Corp. Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
ATE479762T1 (de) * 2004-09-29 2010-09-15 Collplant Ltd Kollagenproduzierende pflanzen sowie verfahren zu deren erzeugung und verwendung
US8455717B2 (en) 2004-09-29 2013-06-04 Collplant Ltd. Collagen producing plants and methods of generating and using same
CN101278052A (zh) 2005-07-18 2008-10-01 普罗塔里克斯有限公司 生物活性大分子的粘膜或肠给药
WO2007041627A1 (en) 2005-10-03 2007-04-12 Pinsky Mark A Compositions and methods for improved skin care
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
EP2220246B1 (de) * 2007-10-26 2015-05-20 Collplant Ltd. Verfahren zur prozessierung von rekombinantem procollagen
AU2008345068A1 (en) * 2007-12-26 2009-07-09 Mark A. Pinsky Collagen formulations for improved skin care
CA2721507C (en) 2008-04-18 2017-10-03 Collplant Ltd. Methods of generating and using procollagen
JP5737597B2 (ja) 2009-11-19 2015-06-17 浙江大学 非天然コラーゲン様タンパク質及びその応用
EP2504472A1 (de) 2009-11-24 2012-10-03 Collplant Ltd. Verfahren zur erzeugung von kollagenfasern
US9732321B2 (en) 2010-02-16 2017-08-15 The General Hospital Corporation Engineered craniofacial constructs with composite scaffold
EP2640877A2 (de) 2010-11-16 2013-09-25 Collplant Ltd. Kollagenstrukturen und herstellungsverfahren dafür
WO2013093921A1 (en) 2011-12-20 2013-06-27 Collplant Ltd. Collagen coated synthetic polymer fibers
CA2907680A1 (en) 2013-03-21 2014-09-25 Collplant Ltd. Compositions comprising collagen and prp for tissue regeneration
CN114225013A (zh) 2015-12-23 2022-03-25 菲尼克斯组织修复公司 胶原蛋白7的组合物及其使用方法
US11377490B2 (en) 2017-05-31 2022-07-05 Sichuan Clover Biopharmaceuticals, Inc Method for treating cancer using disulfide-linked trimeric 4-1BBL
BR112018068682A2 (pt) * 2017-07-18 2019-04-02 Modern Meadow, Inc. ?artigo, e, método para produção de um artigo?
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
CA3099139A1 (en) 2018-05-03 2019-11-07 Collplant Ltd. Dermal fillers and applications thereof
GB2579036A (en) * 2018-11-15 2020-06-10 Rejuvenated Ltd Compositions comprising amino acids
CN113993885B (zh) 2019-04-12 2025-04-25 格尔托公司 重组弹性蛋白及其生产
FR3105792B1 (fr) 2019-12-26 2022-08-12 Michel Assor Matériau biocomposite collagène/matrice polymérique poreuse et son utilisation comme implant de réparation de lésions méniscales du genou et/ou de prévention ou de traitement de l’arthrose du genou
GB2610313B (en) 2020-01-24 2024-07-03 Geltor Inc Animal-free dietary collagen
WO2021229577A1 (en) 2020-05-12 2021-11-18 Collplant Ltd. Collagen as a delivery tool for metal-based anti-viral agents
WO2021249011A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Hiv vaccine compositions, methods, and uses thereof
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
CN119173524A (zh) 2022-04-04 2024-12-20 斯威夫特制药有限责任公司 在植物中产生的重组蜘蛛丝强化的胶原蛋白及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
ATE188253T1 (de) * 1991-10-23 2000-01-15 Univ Jefferson Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen
FR2685347A1 (fr) * 1991-12-23 1993-06-25 Univ Pasteur Procede biotechnologique d'obtention et de production microbienne d'oligomeres peptidiques comme substituts de la gelatine.
JP3639592B2 (ja) * 1992-04-15 2005-04-20 セムバイオシス ジェネティック インコーポレイテッド 植物中の高価値ペプチドの担体用の油体タンパク質
US5693506A (en) * 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
WO1997004123A1 (en) * 1995-07-19 1997-02-06 Gel Tech Group Inc. Collagen compound production in plants
WO1998006861A2 (en) * 1996-08-15 1998-02-19 Agrivax Incorporated Delivery of tolerogenic antigens via edible plants or plant-derived products

Also Published As

Publication number Publication date
US20030096973A1 (en) 2003-05-22
AU5563798A (en) 1998-07-15
FR2757874B1 (fr) 2003-04-25
US6617431B1 (en) 2003-09-09
EP0951537A1 (de) 1999-10-27
DE69734528T2 (de) 2006-07-27
JP2001507573A (ja) 2001-06-12
WO1998027202A1 (fr) 1998-06-25
DE69734528D1 (de) 2005-12-08
EP0951537B1 (de) 2005-11-02
FR2757874A1 (fr) 1998-07-03
CA2274807A1 (fr) 1998-06-25

Similar Documents

Publication Publication Date Title
ATE308614T1 (de) Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung
ATE402260T1 (de) Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung
DE60126920D1 (de) Stress-gekoppeltes zellzyklus protein sowie dessen verwendung in pflanzen
DE3582093D1 (de) Verfahren zur herstellung von sauerstoff als nebenprodukt bei der erzeugung von turbinenstrom.
ATE268788T1 (de) Verfahren zur herstellung von polyisocyanaten
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
WO2001029242A3 (en) Post-translational modification of recombinant proteins produced in plants
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
ATE152124T1 (de) Wachstumsfaktor aus parenchymalen lebenszellen, dafür kodierendes gen, verfahren zur herstellung dieses faktors und transformanten
ATE173653T1 (de) Hydrierungskatalysator, verfahren zur herstellung dieses katalysators und seine verwendung bei der herstellung von wasserstoffperoxid
DE10348116A1 (de) CO-Generator
DE60228822D1 (de) Stress-resistenz als selektierbarer marker in transgenen pflanzen
DE68911680D1 (de) Verfahren zur herstellung von copolyarylensulfiden mit verwendung eines sauerstoffhaltigen gases.
AR008295A1 (es) Celulas inmortalizadas, y metodo para producir y usar dichas celulas para la produccion de virus.
DE69332148D1 (de) Verwendung einer dna sequenz, kodierende für ein protein mit der fäligkeit oxalsäure abzubauen, zur genselektion
DE69317656D1 (de) Inomer-zusammensetzungen, verfahren zur herstellung und verwendung davon, und umwandlungsverfahren dazu
SE8603007L (sv) Sett att framstella 5-aminosalicylsyra
ATE183493T1 (de) Verfahren zur herstellung von 3.3.5- trimethylcyclohexanon
DE60234101D1 (de) Durch verstärktes wachstum charakterisierte pflanzen sowie für deren erzeugung geeignete verfahren und nukleinsäurekonstrukte
DE68920358D1 (de) Verfahren zur Herstellung von Schwefelwasserstoff.
DE69838459D1 (de) Für den licht-überempfinlichkeitsphaenotyp kodierende nukleotidsequenzen von tomaten, dadurch kodierte proteine und deren verwendungen
DE3486163D1 (de) Plasmide, verfahren zu ihrer herstellung, sie enthaltende mikroorganismen und methoden zur extrazellulaeren herstellung von xylanase durch zuechten dieser mikroorganismen.
ATE364082T1 (de) Verfahren zur herstellung von pflanzen mit erhöhter resistenz gegen wasserstress
EP0355646A3 (de) Verfahren zur Herstellung von unverzweigten Polyarylensulfiden mit verbesserter Farbqualität und Farbstabilität
ATA186592A (de) Nukleotidsequenz, die für den transforming growth faktor-beta2 kodiert, transforming growth faktor-beta2 sowie verfahren und zellen zur herstellung desselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties